Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.61 USD | +2.79% | +2.56% | -9.27% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.27% | 492M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-0.61% | 21.83B | |
-10.84% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- URGN Stock
- News UroGen Pharma Ltd.
- Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024